Zaza G - Search Results

1

Donor-transmitted cancer in kidney transplant recipients: a systematic review.

Eccher A, Girolami I, Motter JD, Marletta S, Gambaro G, Momo REN, Nacchia F, Donato P, Boschiero L, Boggi U, Lombardini L, Cardillo M, D'Errico A, Neil D, Segev DL, Zaza G. Eccher A, et al. Among authors: zaza g. J Nephrol. 2020 Dec;33(6):1321-1332. doi: 10.1007/s40620-020-00775-4. Epub 2020 Jun 13. J Nephrol. 2020. PMID: 32535833 Free PMC article.

2

A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition.

Masola V, Onisto M, Zaza G, Lupo A, Gambaro G. Masola V, et al. Among authors: zaza g. J Transl Med. 2012 Oct 24;10:213. doi: 10.1186/1479-5876-10-213. J Transl Med. 2012. PMID: 23095131 Free PMC article.

3

Renal biopsy in chronic kidney disease: lessons from a large Italian registry.

Zaza G, Bernich P, Lupo A; 'Triveneto' Register of Renal Biopsies (TVRRB). Zaza G, et al. Am J Nephrol. 2013;37(3):255-63. doi: 10.1159/000348566. Epub 2013 Mar 13. Am J Nephrol. 2013. PMID: 23485642

4

Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitors.

Zaza G, Tomei P, Ria P, Granata S, Boschiero L, Lupo A. Zaza G, et al. Clin Dev Immunol. 2013;2013:403280. doi: 10.1155/2013/403280. Epub 2013 Sep 19. Clin Dev Immunol. 2013. PMID: 24151517 Free PMC article. Review.

5

Dialysis-related transcriptomic profiling: the pivotal role of heparanase.

Zaza G, Masola V, Granata S, Pontrelli P, Sallustio F, Gesualdo L, Gambaro G, Grandaliano G, Lupo A. Zaza G, et al. Exp Biol Med (Maywood). 2014 Jan;239(1):52-64. doi: 10.1177/1535370213506678. Epub 2013 Nov 4. Exp Biol Med (Maywood). 2014. PMID: 24189015 Clinical Trial.

6

Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase.

Masola V, Zaza G, Granata S, Gambaro G, Onisto M, Lupo A. Masola V, et al. Among authors: zaza g. J Transl Med. 2013 Nov 20;11:292. doi: 10.1186/1479-5876-11-292. J Transl Med. 2013. PMID: 24256696 Free PMC article.

7

Sulodexide and glycosaminoglycans in the progression of renal disease.

Masola V, Zaza G, Gambaro G. Masola V, et al. Among authors: zaza g. Nephrol Dial Transplant. 2014 Feb;29 Suppl 1:i74-i79. doi: 10.1093/ndt/gft389. Nephrol Dial Transplant. 2014. PMID: 24493873 Review.

8

Monoclonal antibody therapy and renal transplantation: focus on adverse effects.

Zaza G, Tomei P, Granata S, Boschiero L, Lupo A. Zaza G, et al. Toxins (Basel). 2014 Feb 28;6(3):869-91. doi: 10.3390/toxins6030869. Toxins (Basel). 2014. PMID: 24590384 Free PMC article. Review.

9

mTOR inhibitors and renal allograft: Yin and Yang.

Zaza G, Granata S, Tomei P, Masola V, Gambaro G, Lupo A. Zaza G, et al. J Nephrol. 2014 Oct;27(5):495-506. doi: 10.1007/s40620-014-0103-y. Epub 2014 May 8. J Nephrol. 2014. PMID: 24804854 Review.

10

Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity.

Masola V, Zaza G, Secchi MF, Gambaro G, Lupo A, Onisto M. Masola V, et al. Among authors: zaza g. Biochim Biophys Acta. 2014 Sep;1843(9):2122-8. doi: 10.1016/j.bbamcr.2014.06.005. Epub 2014 Jun 15. Biochim Biophys Acta. 2014. PMID: 24937189 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page